8-K
Current Report
Niagen Bioscience, Inc. Filed Acc 0001415889-14-003779
Material agreement · Acquisition or sale completed · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading form8k-12032014_061203.htm…